Reaven E P, Reaven G M
J Cell Biol. 1978 Jun;77(3):735-42. doi: 10.1083/jcb.77.3.735.
The fact that colchicines inhibits hepatic secretion of very low density lipoprotein (VLDL) particles has been interpreted to mean that microtubules are involved in hepatic VLDL secretion. To further define this relationship, we have attempted to see if changes in hepatic VLDL secretion are associated with changes in hepatocyte microtubule or tubulin content. Accordingly, hepatic secretion of VLDL was increased in rats, and the hepatocyte content of both microtubules (using quantitative morphometric methods) and tubulin (using a time-decay colchicine binding assay) was determined. In acute experiments, VLDL secretion was increased by perfusion of isolated rat livers for 2 h with varying concentrations of free fatty acids (FFA). Results indicate that hepatic VLDL triglyceride (TG) secretion at perfusate FFA levels of 0.7 muEq/ml is threefold greater (P < 0.01) than when livers are perfused without added FFA. However, no differences are observed in the content of microtubules in these livers: specifically, microtubules occupy 0.029 percent of hepatocyte cytoplasm in livers perfused without FFA and 0.030 percent of cytoplasm in livers perfused with FFA. In chronic experiments, rats were fed for 1 wk with either standard rat chow or a hyperlipidemic (sucrose/lard) diet. With the experimental diet, plasma triglyceride levels increase threefold over controls, and liver VLDL-TG production, as determined by [(3)H]glycerol turnover studies, is 55 percent greater (P < 0.01) than controls. However, microtubules occupy 0.027 percent of the cytoplasm of hepatocyte cytoplasm whether rats are on standard or hyperlipidemic diets. Furthermore, the tubulin content of isolated hepatocytes does change, and represents 1 percent of hepatocyte soluble protein, irrespective of diet. These results suggest that increases in hepatic VLDL secretion can occur without any demonstrable change in hepatocyte assembled microtubule or tubulin content, and raise questions as to the role played by microtubules in hepatic VLDL secretion.
秋水仙碱抑制极低密度脂蛋白(VLDL)颗粒的肝脏分泌,这一事实被解释为意味着微管参与肝脏VLDL分泌。为了进一步明确这种关系,我们试图观察肝脏VLDL分泌的变化是否与肝细胞微管或微管蛋白含量的变化相关。因此,我们提高了大鼠肝脏VLDL的分泌,并测定了微管(使用定量形态计量学方法)和微管蛋白(使用时间衰减秋水仙碱结合试验)的肝细胞含量。在急性实验中,通过用不同浓度的游离脂肪酸(FFA)灌注分离的大鼠肝脏2小时来增加VLDL分泌。结果表明,灌注液FFA水平为0.7μEq/ml时,肝脏VLDL甘油三酯(TG)分泌比未添加FFA灌注肝脏时增加了三倍(P<0.01)。然而,这些肝脏中微管的含量没有差异:具体而言,未添加FFA灌注的肝脏中微管占肝细胞细胞质的0.029%,而添加FFA灌注的肝脏中微管占细胞质的0.030%。在慢性实验中,给大鼠喂食标准大鼠饲料或高脂血症(蔗糖/猪油)饲料1周。采用实验性饲料时,血浆甘油三酯水平比对照组增加了三倍,并且通过[(3)H]甘油周转率研究测定,肝脏VLDL-TG产量比对照组高55%(P<0.01)。然而,无论大鼠食用标准饲料还是高脂血症饲料,微管都占肝细胞细胞质的0.027%。此外,分离的肝细胞中微管蛋白的含量没有变化,且无论饲料如何,均占肝细胞可溶性蛋白的1%。这些结果表明,肝脏VLDL分泌增加时,肝细胞组装的微管或微管蛋白含量没有任何可证明的变化,并对微管在肝脏VLDL分泌中所起的作用提出了疑问。